Pulse nav.journalClub Tendances Explorer Questions Chercheurs

Download the App

Join discussions, follow papers, and never miss your next session.

© Synapse Social LLC, 2026Politique de confidentialité

Accueil Explorer nav.journalClub Tendances

⌘+K

RNA Sequencing to Predict Response to Neoadjuvant Anti-HER2 Therapy | Synapse

September 29, 2016Open Access

RNA Sequencing to Predict Response to Neoadjuvant Anti-HER2 Therapy

Key Points

Key points are not available for this paper at this time.

Abstract

clinicaltrials.gov Identifier: NCT00553358.

Like

Bookmark

Share

View Full Paper

Like

Bookmark

Share

View Full Paper

Cite This Study

Fumagalli et al. (Thu,) studied this question.

synapsesocial.com/papers/69d7b74656b4d8a54e48f67b https://doi.org/https://doi.org/10.1001/jamaoncol.2016.3824

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1STAR: ultrafast universal RNA-seq aligner2012 · 55,975 citations
2Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial2011 · 2,350 citations
3The <tt>sva</tt> package for removing batch effects and other unwanted variation in high-throughput experiments2012 · 6,695 citations
4Untitled2002 · 5 citations
5Trimmomatic: a flexible trimmer for Illumina sequence data2014 · 69,426 citations